Drottninggatan 29 Box 603, Stockholm, Stockholm, 101 32, Sweden


From early development through to commercial manufacturing. The brightest minds in the CDMO industry.

Recipharm is a leading global pharmaceutical Contract Development and Manufacturing Organisation (CDMO). We provide pharmaceutical companies around the world with tailor-made development and manufacturing services, including a wide variety of drug dosage forms, and inhalation products and devices.

Our comprehensive services cover the entire life cycle of a pharmaceutical product – from drug substance through to commercial manufacturing – to get products to market in a timely and cost-efficient way. 

Our core values

Tenacity - We show commitment in everything we do. We are committed to reaching our goals. We are persistent and we will not give up easily. If we encounter an obstacle, we try harder to find a solution. 

Professionalism - We maintain a high level of competence to deliver a return on investment to our stakeholders. We are flexible, service minded and always looking for the best solutions. We learn from our mistakes. We show respect - to customers, peers, partners, managers and to the environment. 

Reliability - We create trust by always delivering on promises. We deliver with quality and in time. We are honest and always follow our code of conduct. 

Entrepreneurship - We are innovative and creative in finding ways to develop and improve our business. We are open to change but respect that it can take time to achieve. We have a "can do" attitude and always take on challenges with a mindset that nothing is too difficult.

Our history

Our company began its journey back in 1995 with the management buyout of a solid dose facility in Stockholm, including a portfolio of around 20 well-known pharmaceutical products.

Over the years, Recipharm has continued to grow organically and through the acquisition of 30 + facilities to become the fourth largest global CDMO.

In March 2021, Recipharm AB was delisted from the stock exchange and became a private company owned by private equity firm EQT IX. 

Today, Recipharm remains headquartered in Sweden and now includes around 30 manufacturing and development facilities in Europe, India, Israel and North America. The company is one of the oldest and most experienced CDMOs in the world and we are proud of what we have achieved.